Donor follow-up will be initiated after the first injection of a mobilizing agent, the administration of anesthesia, or the beginning of apheresis (in case of MNC Apheresis), independently of completion of the collection. The donor’s health must be assessed to monitor the recovery process, long-term health effects after the donation and the availability for further donations.
To ensure donor’s and recipient’s health and safety, all adverse events and reactions of unrelated donors or patients have to be reported to WMDA to gain insight in the occurrence of health incidents or risks. This also applies to MNC Apheresis.
SEAR Reporting
SPEAR Reporting